PB 38 of 2013

National Health (Weighted average disclosed price – supplementary disclosure cycle A) Amendment Determination 2013 (No. 1)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this amendment determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated   4 July 2013

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

 

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

 

1 Name of Determination

 (1) This Determination is the National Health (Weighted average disclosed price – supplementary disclosure cycle A) Amendment Determination 2013 (No. 1).

 (2) This Determination may also be cited as PB 38 of 2013.

2 Commencement

  This Determination commences on the day after it is registered.

 

 

3 Amendments to PB 24 of 2013

Schedule 1 amends the National Health (Weighted average disclosed price – supplementary disclosure cycle A) Determination 2013 (PB 24 of 2013).

Schedule 1    Amendments

 

 

[1]  Schedule 1

 

 after:

 

12

Temozolomide

Capsule 140 mg

Oral

Temizole 140

627.72

 

insert:

 

12A

Temozolomide

Capsule 180 mg

Oral

Temodal

795.30

 

 

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.comlaw.gov.au/Home.